What are the cardiovascular complications of the analgesics and glucocorticoids?;Quelles sont les complications cardiovasculaires des antalgiques et des glucocorticoides?

Presse Medicale

Volumn 35, Issue 9 SUPPL. 1, 2006, Pages 47-51

  Dufauret Lombard, Carine ^a   Bertin, Philippe ^a  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; BETAMETHASONE; CHLORIDE; CODEINE; CORTICOSTEROID; CORTISONE; DEXAMETHASONE; DEXTROPROPOXYPHENE; GLUCOCORTICOID; HYDROCORTISONE; METHYLPREDNISOLONE; MORPHINE; NALBUPHINE; NEFOPAM; OPIATE; PARACETAMOL; PENTAZOCINE; PREDNISOLONE; PREDNISONE; TRAMADOL; TRIAMCINOLONE;

ARTICLE; ATHEROSCLEROSIS; BRADYCARDIA; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY THROMBOSIS; CORTICOSTEROID THERAPY; DRUG OVERDOSE; DYSLIPIDEMIA; HEART FAILURE; HUMAN; HYPERTENSION; HYPOKALEMIA; LOW DRUG DOSE; LUNG EDEMA; MUSCULOSKELETAL PAIN; PATIENT MONITORING; PERICARDITIS; PRESCRIPTION; VAGUS NERVE STIMULATION; RISK FACTOR;

ACETAMINOPHEN; ANALGESICS; CARDIOVASCULAR DISEASES; DYSLIPIDEMIAS; GLUCOCORTICOIDS; HUMANS; HYPERTENSION; HYPOKALEMIA; PRESCRIPTIONS, DRUG; RISK FACTORS;

EID: 33751556988     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0755-4982(06)74940-5     Document Type: Article

References (37)

1. Merlo J, Broms K, Lindblad U, et al. Association of out-patient utilisation of non-steroidal anti-inflammatory drugs and hospitalised heart failure in the entire Swedish population. Eur J Clin Pharmacol 2001; 57: 71-5.
2. Dedier J, Stampfer MJ, Hankinson SE, Willett WC, Speizer FE, Curhan GC. Nonnarcotic analgesic use and the risk of hypertension in US woman. Hypertension 2002; 40: 604-8.
3. Curhan GC, Willett WC, Rosner B, Stampfer MJ. Frequency of analgesic and the risk of hypertension in younger women. Arch Intern Med 2002; 162: 2204-8.
4. Radack KL, Deck CC, Bloomfield SS. Ibuprofen interferes with the efficacy of antihypertensive drugs. A randomized, double-blind, placebo-controlled trial of ibuprofen compared with acetaminophen. Ann Int Med 1987; 107: 628-35.
5. Hylek EM, Heiman H, Skates SJ, Sheehan MA, Singer DE. Acetaminophen and other risk factors for excessive warfarin anticoagulation. JAMA 1998; 279: 657-62.
6. American College of Rheumatology Subcommittee on osteoarthritis guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee. Arthritis Rheum 2000; 43: 1905-15.
7. Kwan D, Bartle WR, Walker SE. The effects of acetaminophen on pharmacokinetics and pharmacodynamics of warfarin. J Clin Pharmacol 1999; 39: 68-75.
8. Scott LJ, Perry CM. Tramadol: a review of its use in perioperative pain. Drugs 2000; 60: 139-76.
9. Krantz MJ, Garcia JA, Mehler PS. Tramadol-associated pericarditis. Int J Cardiol 2005; 99: 497-8.
10. Garrett PM. Tramadol overdose and serotonin syndrome manifesting as acute right heart dysfunction. Anaesth Intensive Care 2004; 32: 575-7.
11. Bannwarth B. Analgésiques non morphiniques. Principes et règles d'utilisation. Rev Prat 1996; 46: 1025-30.
12. Jacobi J, Fraser GL, Coursin DB, et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adults. Crit Care Med 2002; 30: 119-41.
13. Dahaba AA, Grabner T, Rehak PH, List WF, Metzler H. Remifentanil versus morphine analgesia and sedation for mechanically ventilated critically ill patients: a randomized double blind study. Anesthesiology 2004; 101: 640-6.
14. Krantz MJ, Kutinsky IB, Robertson AD, Mehler PS. Dose-related effects of methadone on QT prolongation in a series of patients with torsade de pointes. Pharmacotherapy 2003; 23: 802-5.
15. Kornick CA, Kilborn MJ, Santiago-Palma J. et al. QTc interval prolongation associated with intravenous methadone. Pain 2003; 105: 499-506.
16. Ng MK, Celermajer DS. Glucocorticoid treatment and cardiovascular disease. Heart 2004; 90: 829-30.
17. Kelly JJ, Mangos G, Williamson PM, Whitworth JA. Cortisol and hypertension. Clin Exp Pharmacol Physiol 1998; 25: S51-6.
18. Schacke H, Docke WD, Asadullah K. Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther 2002; 96: 23-43.
19. Andrews RC, Walker BR. Glucocorticoids and insulin resistance: old hormones, new targets. Clin Sci 1999; 96: 513-23.
20. Weber KT. Aldosterone in congestive heart failure. N Engl J Med 2001; 345: 689-97.
21. Souverein PC, Berard A, Van Staa TP, Cooper C, Egberts AC, Leufkens HG, Walker BR. Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study. Heart 2004; 90: 859-65.
22. Wei L, MacDonald TM, Walker BR. Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. Ann Intern Med 2004; 141: 764-70.
23. Summary for patients in: Ann Intern Med 2004; 141: I58.
24. Davis JM 3rd, Maradit-Kremers H, Gabriel SE. Use of low-dose glucocorticoids and the risk of cardiovascular morbidity and mortality in rheumatoid arthritis: what is the true direction of effect? J Rheumatol 2005; 32: 1856-62.
25. Sattar N, McCarey DW, Capell H, McInnes IB. Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 2003; 108: 2957-63.
26. Girod JP, Brotman DJ. Does altered glucocorticoid homeostasis increase cardiovascular risk? Cardiovasc Res 2004; 64: 217-26.
27. Nesbitt LT Jr. Minimizing complications from systemic glucocorticosteroid use. Dermatol Clin 1995; 13: 925-39.
28. Some Nina K, Lorette G, Chantepie A, Villerette C, Machet L. Hypertrophic cardiomyopathy associated with oral corticosteroid therapy for palpebral hemangioma. Ann Dermatol Venereol 2004; 131: 263-5.
29. Lilien LD, Lilien RH, Setrakian S. Hemopericardium and cardiac tamponade as presenting findings of dexamethasone induced hypartrophic cardiomyopathy complicated by transmural myocardial infarction. Pediatr Cardiol 2003; 24: 280-3.
30. Pokorny J, Roth F, Balfour I, Rinehart G. An unusual complication of the treatment of a hemangioma. Ann Plast Surg 2002; 48: 83-7.
31. Aslam AK, Vasavada BC, Sacchi TJ, Khan IA. Atrial fibrillation associated with systemic lupus erythematosus and use of methylprednisolone. Am J Ther 2001; 8: 303-5.
32. American College of Rheumatology Subcommitee on osteoarthiritis guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee. Arthritis Rheum 2000; 43: 1905-15.
33. American Pain Society. Guideline for the management of pain in osteoarthritis, rheumatoid arthritis, and juvenile chronic arthritis. Glenview: APS, 2002.
34. Pendleton A, Arden N, Dougados M et al. EULAR recommendations 2003 for the management of knee osteoarthritis: report of a task force of the Standing Committee for international clinical studies including therapeutic trials (ESCISIT). Ann Rheum Dis 2003; 62: 1145-55.
35. Burton AK, Waddell G. Clinical guidelines in the management of low back pain. Clinical guidelines and guidance review. Royal College of General Practitioners. Ballière's Clinical Rheumatology 1998; 12: 16-35.
36. ANAES. Diagnostic, prise en charge et suivi des malades atteints de lombalgie chronique. Recommendations pour la pratique clinique. Paris: ANAES, octobre 2000.
37. AGS clinical practice guidelines: the management of chronic pain in older persons. Geriatrics 1998; 53 (suppl): 1-24.